Fact CheckerSign in

NCT07583680Not yet recruiting

A Clinical Study Used to Estimate Central Venous Pressure Non-invasively Using Occlusion Pressure

Non-Invasive Central Venous Pressure Estimation Using Occlusion Pressure: A Novel Approach for Accurate Hemodynamic Monitoring

Source: ClinicalTrials.gov · Last updated 13 May 2026

Brief summary (registry, in English)

The purpose of this study is to collect different measurements using a method called peripheral venous pressure (PVP). PVP checks the pressure in the veins in the arms or legs. It can give doctors a good idea of how well the heart is working, similar to another method called central venous pressure (CVP), which doctors use in hospitals. In this study, the research team will measure PVP in people aged 0-17. The researcher hopes that this data will help doctors understand how PVP measurements relate to health outcomes, which could lead to better ways to diagnose and treat patients in the future. The peripheral venous pressure (PVP) device will be used to non-invasively measure the pressure required to stop blood flow in the forearm, which will indirectly measure the PVP in the forearm. This device is composed of a pressure sensor and a Doppler flow detector that will be connected to a research laptop for data collection. This device will be placed on the forearm. If you agree to be in this study, the study team will monitor the venous flow rate (the amount of blood moving through the veins over a certain period of time) using a Doppler Flow Detector while applying pressure to the vein with a pressure sensor. This will take place on the forearm. The internal jugular vein will be identified and recorded using ultrasound imaging and Doppler sensor. The forearm vein will be identified and marked using ultrasound imaging. Pressure will be applied for 15 seconds, and then stopped and repeated 4 times, making five sets of measurements. The procedure may be repeated in 2-3 additional sessions during the hospital stay, if necessary. Your participation in this study will last approximately 30 minutes. This procedure is for research only and will not affect your regular care. This will occur during your child's stay in the PCICU/PICU. No additional study visits will be required. The following procedures are being performed for research purposes only: Copying information such as your medical history from your medical record; Obtaining non-invasive peripheral venous pressure measurements.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
30 (estimated)
First submitted
1 May 2026
Start date
Jul 2026
Primary completion date
Jul 2027
Lead sponsor
Le Bonheur Children's Hospital
NCT number
NCT07583680

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From Jul 2026 to the primary completion date, Jul 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Heterotaxy Syndrome Patients

Other

  • Glenn and Fontan Patients
  • Inability to consent by guardian/caretaker

Who the study is looking for

  • Admitted to PICU or PCICU
  • Provided written informed consent
  • Continuous Central venous pressure monitoring transduced from a standard central venous catheter (not PICC line)

Age in the registry: - to 17 years · Sex: All

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.